SecBot SecBot

BTAIQ

BioXcel Therapeutics, Inc.
OTC· CIK 0001720893 Biotech & Drug Discovery
$0.0122 −0.00 (−23.75%)
Oct 27 4:00 PM ET · prev $0.0160
1 year
−99.4%
from $2.18 · Oct 28
30 days
−70.2%
from $0.0410
52-week range
$0.0122–2.25
at the low
Avg volume 20D
264.3K
shares / day
Short interest
1.64M
−16.6%
Days to cover
3.7
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Sep 15 Short interest falls 49.6% to 3.08M
  • X Sep 30 Short interest falls 36.2% to 1.97M

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 5 added (0 new), 3 trimmed or exited.

  • Short sellersCOVERING

    Short interest −16.6% to 1.64M shares. 3.7 days to cover.

  • TrendDOWNTREND

    93% below its 50-day average. New closing low $0.0122 on Oct 27.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED919,545$1.3M
BlackRock, Inc.DOUBLED179,433$253.0K
UBS Group AGDOUBLED158,065$222.9K
VANGUARD FIDUCIARY TRUST COADD136,937$193.1K
JONES FINANCIAL COMPANIES LLLPTRIM63,139$82.7K
NORTHERN TRUST CORPADD56,318$79.4K
MORGAN STANLEYNEAR_EXIT1,671$2.4K
BNP PARIBAS FINANCIAL MARKETSNEAR_EXIT12$17.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026
Recent actions
DateFirmActionRating
Apr 2, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — DOUBLED
919,545 shares ($1.3M)
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
179,433 shares ($253.0K)

Short side

FINRA· Oct 15, 2026
1,641,640
shares short
-16.6%
vs prior settlement
3.7
days to cover